IMV - IMV updates development of DPX-COVID-19 vaccine; shares up 28% premarket March, 30 2020 07:20 AM IMV Inc. IMV (NASDAQ:IMV) provides updates on the development of DPX-COVID-19, a vaccine candidate against coronavirus.More news on: IMV Inc., Healthcare stocks news, Stocks on the move, Read more ...